Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

Michael J. Curtis, Steve Alexander, Giuseppe Cirino, James R. Docherty, Christopher H. George, Mark A. Giembycz, Daniel Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Christopher G. Sobey, S. Clare Stanford, Mauro M. Teixeira, Sue Wonnacott, Amrita Ahluwalia

Research output: Contribution to journalEditorial

131 Citations (Scopus)

Abstract

This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.

LanguageEnglish
Pages987-993
Number of pages7
JournalBritish Journal of Pharmacology
Volume175
Issue number7
Early online date9 Mar 2018
DOIs
StatusPublished - 1 Apr 2018

Fingerprint

Research Design
Guidelines
Peer Review
Compliance
Pharmacology

ASJC Scopus subject areas

  • Pharmacology

Cite this

Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, C. H., Giembycz, M. A., ... Ahluwalia, A. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175(7), 987-993. https://doi.org/10.1111/bph.14153

Experimental design and analysis and their reporting II : updated and simplified guidance for authors and peer reviewers. / Curtis, Michael J.; Alexander, Steve; Cirino, Giuseppe; Docherty, James R.; George, Christopher H.; Giembycz, Mark A.; Hoyer, Daniel; Insel, Paul A.; Izzo, Angelo A.; Ji, Yong; MacEwan, David J.; Sobey, Christopher G.; Stanford, S. Clare; Teixeira, Mauro M.; Wonnacott, Sue; Ahluwalia, Amrita.

In: British Journal of Pharmacology, Vol. 175, No. 7, 01.04.2018, p. 987-993.

Research output: Contribution to journalEditorial

Curtis, MJ, Alexander, S, Cirino, G, Docherty, JR, George, CH, Giembycz, MA, Hoyer, D, Insel, PA, Izzo, AA, Ji, Y, MacEwan, DJ, Sobey, CG, Stanford, SC, Teixeira, MM, Wonnacott, S & Ahluwalia, A 2018, 'Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers', British Journal of Pharmacology, vol. 175, no. 7, pp. 987-993. https://doi.org/10.1111/bph.14153
Curtis, Michael J. ; Alexander, Steve ; Cirino, Giuseppe ; Docherty, James R. ; George, Christopher H. ; Giembycz, Mark A. ; Hoyer, Daniel ; Insel, Paul A. ; Izzo, Angelo A. ; Ji, Yong ; MacEwan, David J. ; Sobey, Christopher G. ; Stanford, S. Clare ; Teixeira, Mauro M. ; Wonnacott, Sue ; Ahluwalia, Amrita. / Experimental design and analysis and their reporting II : updated and simplified guidance for authors and peer reviewers. In: British Journal of Pharmacology. 2018 ; Vol. 175, No. 7. pp. 987-993.
@article{8b6e9f90dbf9481fac5c84d0fd4f5328,
title = "Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers",
abstract = "This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.",
author = "Curtis, {Michael J.} and Steve Alexander and Giuseppe Cirino and Docherty, {James R.} and George, {Christopher H.} and Giembycz, {Mark A.} and Daniel Hoyer and Insel, {Paul A.} and Izzo, {Angelo A.} and Yong Ji and MacEwan, {David J.} and Sobey, {Christopher G.} and Stanford, {S. Clare} and Teixeira, {Mauro M.} and Sue Wonnacott and Amrita Ahluwalia",
year = "2018",
month = "4",
day = "1",
doi = "10.1111/bph.14153",
language = "English",
volume = "175",
pages = "987--993",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Experimental design and analysis and their reporting II

T2 - British Journal of Pharmacology

AU - Curtis, Michael J.

AU - Alexander, Steve

AU - Cirino, Giuseppe

AU - Docherty, James R.

AU - George, Christopher H.

AU - Giembycz, Mark A.

AU - Hoyer, Daniel

AU - Insel, Paul A.

AU - Izzo, Angelo A.

AU - Ji, Yong

AU - MacEwan, David J.

AU - Sobey, Christopher G.

AU - Stanford, S. Clare

AU - Teixeira, Mauro M.

AU - Wonnacott, Sue

AU - Ahluwalia, Amrita

PY - 2018/4/1

Y1 - 2018/4/1

N2 - This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.

AB - This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.

UR - http://www.scopus.com/inward/record.url?scp=85043393318&partnerID=8YFLogxK

U2 - 10.1111/bph.14153

DO - 10.1111/bph.14153

M3 - Editorial

VL - 175

SP - 987

EP - 993

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -